# Pizarra — PT-pseudo_3f75ae876abe (task 1)

---

# Ronda 1

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_3f75ae876abe
Task: 1

Encounter: Urology - outpatient on 01 Jan 2025.
Referrer: Dr. L. Smits (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 69-year-old male
  - PSA: 16.8 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.846 ng/mL²
  - PSA velocity: 3.33 ng/mL/yr
  - Prior PSA: 11.0 ng/mL
  - Prostate volume: 19.86 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.87284654 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.

Vitals: weight 91 kg, height 177 cm, BMI 29.0, BP 111/83 mmHg, HR 66 bpm. Smoking: Current smoker (15 pack-yr).

Chief complaint: Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit.

History: At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket "None". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment.

Physical examination: DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute.

Patient info: retired truck driver; Married; Lives alone.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 16/35 (moderate LUTS).

Recent other appointments: Ophthalmology — cataract review; Endocrine — thyroid screening.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status in the panel above is all the pathology information on record.]

## [2] STATISTICAL PRIOR (classifier)

**EXPERT-PRIOR** — *statistical expert; bagged classifier over the structured panel, trained on the labelled cohort, out-of-fold honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.85 +/- 0.05   (95% CI 0.74-0.95)

Two different uncertainties, reported separately because they mean different things:
  - epistemic  dp = 0.05  — the error bar on this number. It is the spread
    across bootstrap members: how much the answer would move with a different training sample.
  - aleatoric  H  = 0.62 of 1.00 — how mixed the outcome was among
    patients this model cannot tell apart. High H means the disagreement is in the data, not in
    the model, and more labelled cases would not fix it.

TIER 'firm': p +/- 1.96*dp does not cross the 0.5 threshold. Treat it as a strong prior that should only be overturned by explicit contradicting evidence. Measured accuracy in this tier on the labelled cohort: 1.0 over 28 cases.

Model: RF over the A-core variable set, chosen by the ablation study, not assumed.
Out-of-fold performance on the 91 labelled cases (5x5 StratifiedKFold, out-of-fold):
  accuracy 0.714 (majority-class baseline 0.615), AUC 0.789, F1(yes) 0.78.
Variables it could not read for this patient: none.

It has read ONLY the structured panel and the parsed record. It has not reasoned about the
prose of the mpMRI report, and it does not know what this patient's management plan is.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: biopsy-naive.

CRITERION VERDICT: BIOPSY.

The criterion: Biopsy when the mpMRI shows a PI-RADS 3 or higher lesion; defer when PI-RADS is 1-2.

In the labelled cohort this criterion matched the reading urologist in every one of the 24 biopsy-naive cases (20 of them PI-RADS 4-5 and biopsied, 4 of them PI-RADS 2 or unreadable and deferred).

Track record of this criterion on the labelled cohort: 24 of 24 cases matched the reading urologist. Departing from it needs a specific finding from a retrieved document, named explicitly - not a restatement of the panel numbers it already used.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [5] AGENDA (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

AGENDA FOR ROUND 1. These are the documents this case needs opened, and the question each one must answer. Open these and nothing else unless a named question requires it.

  - radiology_report (get_mri_report) -> Does the mpMRI show a PI-RADS 3 or higher lesion?
  - psa_trend (get_psa_trend) -> Is the PSA trend significant enough to warrant biopsy?
  - previous_notes (get_previous_notes) -> What was the prior management context and agreed-upon surveillance pathway?

This case hinges on the detailed findings from the MRI, the PSA trajectory, and the prior management context to confirm the guideline recommendation. Agenda capped at 3 documents; dropped laboratory_results.

## [6] GAPS AND DOUBTS (round 1)

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only considered the structured panel and parsed record, failing to incorporate the context of the PI-RADS 5 score, the PSA velocity (3.33 ng/mL/yr), and the specific clinical context of a biopsy-naive patient.
The prior cannot weigh the high-risk features such as PI-RADS 5 and the rapid PSA velocity against the low prior biopsy status.
The prior does not account for the guideline's specific risk-adapted matrix that links PI-RADS scores with PSA density to predict biopsy necessity.

WHY THE SUGGESTION COULD BE WRONG
The prior suggests BIOPSY with a high probability (0.85), but this may be wrong because the model did not account for the high aleatoric uncertainty ($H=0.62$), indicating high data variability.
The suggestion could be wrong because the guideline criterion is PI-RADS $\ge 3$, which is met, but the guideline also suggests omitting biopsy if PSA density is very low ($< 0.10 \text{ ng/mL/cc}$) and no family history is present, which is a factor the prior ignored.
The prior might be wrong because a high csPCa probability (0.8728) is not adequately balanced against the DRE finding of "Normal" in the structured panel.

WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology report - Does the mpMRI show a PI-RADS 3 or higher lesion?
psa_trend - Is the PSA trend significant enough to warrant biopsy?
previous_notes - What was the prior management context and agreed-upon surveillance pathway?
laboratory panel - What is the patient's PSA density value?

GUIDELINE ANCHOR
The guideline states that biopsy is indicated when the mpMRI shows a PI-RADS 3 or higher lesion, and it provides risk-adapted matrices linking PI-RADS scores with PSA density to guide the decision.

## [7] EVIDENCE REPORT (round 1)

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
{"case_id": "PT-pseudo_3f75ae876abe", "radiology_report": "PI-RADS 5 lesion in the right anterior mid-gland. Prostate volume 19.86 mL. PSAD 0.846 ng/mL/mL. csPCa predicted probability 0.87284654."}
get_psa_trend
{"case_id": "PT-pseudo_3f75ae876abe", "psa_trend": [{"date": "Nov 2022", "val": 2.8}, {"date": "Jul 2023", "val": 5.1}, {"date": "Apr 2024", "val": 9.2}, {"date": "Jan 2025", "val": 16.8}]}
get_previous_notes
{"case_id": "PT-pseudo_3f75ae876abe", "previous_notes": [{"date": "11 Jul 2023", "author": "Dr. L. Smits (GP)", "text": "Prostate-specific antigen concentrations rose from 7.4 ng/mL during November 2022 to 10.0 ng/mL on recent assessment. Digital rectal examination remained unremarkable. Lower urinary tract symptoms are moderate, absent any hematuria or unexplained weight loss."}, {"date": "12 Jan 2023", "author": "Dr. L. Smits (GP)", "text": "An initial prostate-specific antigen reading of 7.4 ng/mL was recorded in November 2022. Sustained elevation above laboratory reference limits was confirmed during a January 2023 follow-up. He is a retired truck driver experiencing moderate lower urinary tract symptoms without acute urinary retention."}]}

NOT RETRIEVED
laboratory_results
Laboratory results were not retrieved because the moderator's agenda did not explicitly require them, and the LLM-1-GAP-ANALYST only listed them as a potential retrieval point, not a required item for this specific decision path.

WHAT THE EVIDENCE SUPPORTS
FOR sampling this patient now:
- MRI report: PI-RADS 5 lesion in the right anterior mid-gland.
- PSA trend: Rapid rise from 2.8 ng/mL (Nov 2022) to 16.8 ng/mL (Jan 2025).
- Previous notes: Patient has a history of rising PSA and is currently being evaluated for persistent elevation.

AGAINST sampling this patient now:
- Previous notes: DRE findings were "Normal".

WHERE THIS LEANS
The evidence strongly supports biopsy due to the high-risk PI-RADS 5 score and the significant, rapid rise in PSA levels, which aligns with the guideline criterion for biopsy.
LEAN: biopsy

[Opened in this round: radiology_report, psa_trend, previous_notes. Open on the board so far: radiology_report, psa_trend, previous_notes.]

## [8] CLOSING CHECK (round 1)

**MODERATOR** — *moderator; owns the agenda and decides whether the conference may close*

THE CONFERENCE MAY CLOSE.

Positions on the table: prior=yes, protocol=yes, evidence=yes.
Consensus: yes — unanimous among those who took a position.
Agenda: requested ['radiology_report', 'psa_trend', 'previous_notes']; opened ['radiology_report', 'psa_trend', 'previous_notes']; still missing nothing.

The retrieved evidence (PI-RADS 5 on MRI and rapid PSA trend) strongly supports the guideline criterion for biopsy. The record is sufficient to proceed to the final decision.

The chair decides on the record as it stands.

## [9] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

The decision to biopsy is supported by convergence across all sources. The guideline criterion mandates biopsy for a PI-RADS 5 lesion, which was retrieved from the MRI report. This was further supported by the rapid PSA trend, showing a rise from 2.8 ng/mL in Nov 2022 to 16.8 ng/mL in Jan 2025. The statistical prior also suggested biopsy, and the retrieved evidence confirmed the high-risk features driving this conclusion.

Variables that carried weight: age=important, psa=decisive, vol=noted, psad=important, pirads=decisive, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes
